J60378 Bortezomib, 99%
SDS
| Dimensioni | Prezzo ($) | Quantità | Disponibilità |
|---|---|---|---|
| 5mg | 126,00 |
|
|
| 10mg | 196,00 |
|
|
| 25mg | 344,00 |
|
|
Bortezomib, 99%
Proprietà chimiche
Applicazioni
A potent, highly selective and reversible inhibitor of the 20S proteasome, Bortezomib is used as an antineoplastic agent, which controls the growth of cancer cells. It is also useful in the treatment of multiple myeloma.
Note
Letteratura
Roelofs, J. Proteasome inhibition by bortezomib: A left hook and a right punch. EBioMedicine 2015, 2 (7), 619-620.
Pantani, L.; Zamagni, E.; Zannetti, B. A.; Pezzi, A.; Tacchetti, P.; Brioli, A.; Mancuso, K.; Perrone, G.; Rocchi, S.; Tosi, P.; Cavo, M. Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes. Ann. Hematol. 2014, 93 (1), 123-128.
Rischio GHS e dichiarazioni precauzionali
Dichiarazioni di rischio (UE): H300-H310-H330-H372
Fatal if swallowed. Fatal in contact with skin. Fatal if inhaled. Causes damage to organs through prolonged or repeated exposure.
Dichiarazioni precauzionali: P301+P310a-P304+P340-P320-P330-P405-P501a
IF SWALLOWED: IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Specific treatment is urgent (see label). Rinse mouth. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.
Altri riferimenti
Prodotti chimici
Scienze della vita
Metalli e materiali
Catalizzatori
